Non-anticoagulant group (n = 50) | Anticoagulant group (n = 27) | P | |
---|---|---|---|
Gender | 0.215 | ||
Male | 26 (52.0%) | 18 (66.7%) | |
Female | 24 (48.0%) | 9 (33.3%) | |
Age (years, mean ± SD) | 59.0 ± 13.0 | 60.4 ± 12.3 | 0.641 |
Etiology | 0.693 | ||
HBV | 14 (28.0%) | 10 (37.0%) | |
PBC | 13 (26.0%) | 3 (11.1%) | |
Alcohol | 11 (22.0%) | 7 (25.9%) | |
NASH | 2 (4.0%) | 2 (7.4%) | |
Drug | 2 (4.0%) | 1 (3.7%) | |
Other | 8 (16.0%) | 4 (14.8%) | |
HCC | 2 (4.0%) | 2 (7.4%) | 0.917 |
History of splenectomy | 5 (10.0%) | 11 (40.7%) | 0.002 |
Child-Pugh score | 0.102 | ||
A | 16 (34.0%) | 15 (55.6%) | |
B | 24 (51.1%) | 11 (40.7%) | |
C | 7 (14.9%) | 1 (3.7%) | |
MELD (mean ± SD) | 6.4 ± 5.5 | 5.2 ± 4.0 | 0.316 |
Laboratory tests | |||
ALB (g/L) | 32.9 ± 4.8 | 34.9 ± 5.0 | 0.094 |
Median bilirubin (umol/L, IQR) | 23.6 (18.4–31.0) | 19.8 (14.4–29.9) | 0.318 |
Median ALT (U/L, IQR) | 18.5 (12.0–27.5) | 18.0 (14.0–30.0) | 0.906 |
Median AST (g/L, IQR) | 32.7 (22.5–41.6) | 27.3 (21.6–35.6) | 0.175 |
Median creatinine (IQR) | 69.0 (60.0–93.8) | 71.6 (57.8–93.6) | 0.498 |
Median PT (s, IQR) | 14.1 (13.2–15.7) | 14.3 (12.7–14.7) | 0.328 |
INR | 1.3 ± 0.2 | 1.2 ± 0.1 | 0.222 |
Median Platelet count (×109/L, IQR) | 74.0 (52.0–102.0) | 97.0 (69.0–195.0) | 0.041 |
Hemoglobin (g/L) | 98.8 ± 22.3 | 110.1 ± 22.2 | 0.040 |
D-dimer (ug/mL, IQR) | 2.5 (1.3–4.3) | 3.2 (1.7–6.2) | 0.484 |
Degree of PV occlusion | 0.753 | ||
Occlusive | 0 (0.0%) | 1 (3.7%) | |
Non-occlusive | 50 (100.0%) | 26 (96.3%) | |
Location of PVT | |||
Main PV | 42 (84.0%) | 22 (81.5%) | 1.000 |
Intrahepatic branch of PV | 21 (42.0%) | 15 (55.6%) | 0.255 |
splenic vein | 13 (26.0%) | 8 (30.8%) | 0.659 |
Mesenteric vein | 16 (32.0%) | 12 (44.4%) | 0.279 |